South & Central America Aortic Valve Replacement Devices Market Forecast to 2030
South & Central America Aortic Valve Replacement Devices Market Forecast to 2030 – Regional Analysis – by Product (Sutureless Valve and Mechanical Valve), Surgery (Minimally Invasive Surgery and Open Surgery), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Advancements in Aortic Valve Replacement Devices Fuels South & Central America Aortic Valve Replacement Devices Market
The development of minimally invasive surgical techniques (MIS), such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter aortic valve replacement is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Moreover, developments in materials and design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and reduced the risk of complications.
A few technological advancements by the players in the aortic valve replacement devices are mentioned below:
• In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company’s extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of serious heart diseases.
• In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.
Therefore, technological advancements are creating lucrative opportunities in the aortic valve replacement devices market.
South & Central America Aortic Valve Replacement Devices Market Overview
The South & Central America aortic valve replacement devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the surge in prevalence of aortic stenosis, initiatives undertaken by various government organizations to create awareness about valve replacement surgeries.
South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Aortic Valve Replacement Devices Market Segmentation
The South & Central America aortic valve replacement devices market is segmented into product, surgery, end user, and country.
Based on product, the South & Central America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger South & Central America aortic valve replacement devices market share in 2022.
Based on surgery, the South & Central America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger South & Central America aortic valve replacement devices market share in 2022.
Based on end user, the South & Central America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest South & Central America aortic valve replacement devices market share in 2022.
Based on country, the South & Central America aortic valve replacement devices market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America aortic valve replacement devices market share in 2022.
Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Artivion Inc, Venus MedTech HangZhou Inc, and Labcor Laboratórios Ltda. , are some of the leading companies operating in the aortic valve replacement devices market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the South & Central America aortic valve replacement devices market was valued at US$ 365.63 million in 2022 and is expected to reach US$ 876.41 million by 2030, registering a CAGR of 11.5% from 2022 to 2030. Rising number of aortic valve replacement surgeries and increasing demand for minimally invasive techniques are among the critical factors attributed to the South & Central America aortic valve replacement devices market expansion.
A surge in research activity is driven by several factors, including growing prevalence of aortic valve diseases, advancements in medical technology, and need for more evidence-based approaches to treatment. Clinical studies are crucial in assessing the safety and efficacy of new surgical techniques, prosthetic valves, and transcatheter interventions. These studies also help identify risk factors, optimize patient selection criteria, and evaluate long-term outcomes to improve patient care and quality of life. As the demand for aortic valve replacement continues to rise, so does the importance of conducting robust clinical trials to provide healthcare professionals and patients with the best available evidence for making informed treatment options. With ongoing research and collaboration between medical institutions, the future of aortic valve replacement looks promising, with the potential for even more innovative and effective approaches on the horizon.
A few technological advancements by the players in the aortic valve replacement devices are mentioned below:
• Trial started in January 2019, innovative device for pain management by millimeter band radiation: electronic-pain killer (EPIKARD).
• Trial started in January 2017, vascular closure device in transcatheter aortic valve replacement. Evaluation of the safety and efficacy of a percutaneous plug-based large-bore vascular closure device for femoral artery closure in an unselected consecutive patient cohort undergoing transcatheter aortic valve implantation in a single-center prospective study.
On the contrary, product recalls hurdle the growth of South & Central America aortic valve replacement devices market.
Based on product, the South & Central America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve segment held 65.7% share of South & Central America aortic valve replacement devices market in 2022, amassing US$ 240.18 million. It is projected to garner US$ 594.23 million by 2030 to expand at 12.0% CAGR during 2022–2030.
Based on surgery, the South & Central America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held 81.7% share of South & Central America aortic valve replacement devices in 2022, amassing US$ 298.85 million. It is projected to garner US$ 741.57 million by 2030 to expand at 12.0% CAGR during 2022–2030.
Based on end user, the South & Central America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held 64.2% share of South & Central America aortic valve replacement devices market in 2022, amassing US$ 234.87 million. It is projected to garner US$ 580.86 million by 2030 to expand at 12.0% CAGR during 2022–2030.
Based on country, the South & Central America aortic valve replacement devices market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 61.9% share of South & Central America aortic valve replacement devices market in 2022. It was assessed at US$ 226.29 million in 2022 and is likely to hit US$ 556.87 million by 2030, exhibiting a CAGR of 11.9% during 2022–2030.
Key players operating in the South & Central America aortic valve replacement devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Artivion Inc, Venus MedTech HangZhou Inc, and Labcor Laboratórios Ltda. , among others.
In May 2023, Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low structural valve deterioration (SVD) rates in bioprosthetic aortic valves with the company’s innovative RESILIA tissue. The data, representing the longest clinical follow-up for Edwards’ bioprosthetic surgical aortic valve with RESILIA tissue with a mean follow-up of 7.7 years, were presented at the 103rd annual meeting of the American Association for Thoracic Surgery. In Feb 2023, Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America aortic valve replacement devices market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America aortic valve replacement devices market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the aortic valve replacement devices market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Aortic Valve Replacement Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
5. South & Central America Aortic Valve Replacement Devices Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Number of Aortic Valve Replacement Surgeries
5.1.2 Increasing Demand for Minimally Invasive Techniques
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Market Opportunities
5.3.1 Advancements in Aortic Valve Replacement Devices
5.4 Future Trends
5.4.1 Increasing Number of Clinical Studies
5.5 Impact Analysis:
6. Aortic Valve Replacement Devices Market – South & Central America Market Analysis
6.1 South & Central America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Mechanical Valve
7.3.1 Overview
7.3.2 Mechanical Valve: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Sutureless Valve
7.4.1 Overview
7.4.2 Sutureless Valve: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Surgery.
8.1 Overview
8.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
8.3 Open Surgery
8.3.1 Overview
8.3.2 Open Surgery: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Minimally Invasive Surgery
8.4.1 Overview
8.4.2 Minimally Invasive Surgery: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by End User.
9.1 Overview
9.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Aortic Valve Replacement Devices Market – Country Analysis
10.1 South & Central America Aortic Valve Replacement Devices Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 South & Central America Aortic Valve Replacement Devices Market by Country
10.1.2.1 Brazil
10.1.2.1.1 Overview
10.1.2.1.2 Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 Brazil Aortic Valve Replacement Devices Market, by Product
10.1.2.1.4 Brazil Aortic Valve Replacement Devices Market, by Surgery
10.1.2.1.5 Brazil Aortic Valve Replacement Devices Market, by End-User
10.1.2.2 Argentina
10.1.2.2.1 Overview
10.1.2.2.2 Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 Argentina Aortic Valve Replacement Devices Market, by Product
10.1.2.2.4 Argentina Aortic Valve Replacement Devices Market, by Surgery
10.1.2.2.5 Argentina Aortic Valve Replacement Devices Market, by End-User
10.1.2.3 Rest of South & Central America
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 Rest of South & Central America Aortic Valve Replacement Devices Market, by Product
10.1.2.3.4 Rest of South & Central America Aortic Valve Replacement Devices Market, by Surgery
10.1.2.3.5 Rest of South & Central America Aortic Valve Replacement Devices Market, by End-User
11. Global Aortic Valve Replacement Devices Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in South & Central America Aortic Valve Replacement Devices Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Key Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica Industry, Commerce and Representations Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Artivion Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Venus MedTech HangZhou Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Labcor Laboratórios Ltda.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Aortic Valve Replacement Devices Market Segmentation
Table 2. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 3. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 4. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 5. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 6. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 7. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 8. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 9. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 10. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 11. Recent Organic Growth Strategies in Aortic Valve Replacement Devices Market
Table 12. Recent Inorganic Growth Strategies in the Aortic Valve Replacement Devices Market
Table 13. Glossary of Terms, Aortic Valve Replacement Devices Market
LIST OF FIGURES
Figure 1. South & Central America Aortic Valve Replacement Devices Market Segmentation, By Country
Figure 2. South & Central America – PEST Analysis
Figure 3. South & Central America Aortic Valve Replacement Devices Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. South & Central America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
Figure 6. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Mechanical Valve: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sutureless Valve: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Surgery 2022 & 2030 (%)
Figure 10. Open Surgery: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Minimally Invasive Surgery: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 13. Hospitals & Clinics: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Ambulatory Surgery Centers: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: South & Central America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Aortic Valve Replacement Devices Market, By country, 2022 ($Mn)
Figure 17. South & Central America Aortic Valve Replacement Devices Market, By Key Countries, 2022 and 2030 (%)
Figure 18. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
Figure 20. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Growth Strategies in South & Central America Aortic Valve Replacement Devices Market
The List of Companies – South & Central America Aortic Valve Replacement Devices Market
o Abbott Laboratories
o Artivion Inc
o Boston Scientific Corp
o Braile Biomedica Industry, Commerce and Representations Ltd
o Edwards Lifesciences Corp
o Labcor Laboratórios Ltda.
o LivaNova Plc
o Medtronic Plc
o Venus MedTech HangZhou Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.